The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback